NCT07130136View on ClinicalTrials.gov

Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients

NANot yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

October 31, 2027

Conditions
Bone ConductionHearing Loss, ConductiveHearing Loss, Mixed
Interventions
DEVICE

Cochlear™ Osia® System

The Osia System consists of the OSI300 Implant, Osia 2 Sound Processor, Osia 2 Sound Processor Magnets, Osia 2 Sound Processor Magnet Tool, Osia Fitting Software 2 (OFS 2), and Osia Smart App.

DEVICE

Cochlear™ Baha® System

The Baha Connect System consists of the BIA300 (BI300 Implant and BA300 Abutment), Baha 7 Sound Processor, and Baha Fitting Software 7 (BFS 7).

Trial Locations (4)

CH2 1UL

Countess of Chester Hospital, Chester

WC1E 6DG

Royal National Ear, Nose and Throat and Eastman Dental Hospitals, London

NG1 5DU

Nottingham Auditory Implant Programme, Nottingham

S10 2JF

Sheffield Teaching Hospitals, Sheffield

Sponsors

Lead Sponsor

Cochlear
All Listed Sponsors
collaborator

TFS HealthScience

UNKNOWN

lead

Cochlear

INDUSTRY

NCT07130136 - Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients | Biotech Hunter | Biotech Hunter